Bezirkskrankenhaus St. Johann
- Address
- lock Available on a paid plan
Bezirkskrankenhaus St. Johann - Cardiovascular Research Center
Bezirkskrankenhaus St. Johann is actively engaged in advanced cardiovascular research, with particular emphasis on secondary prevention and risk management following acute myocardial infarction. The center specializes in innovative approaches to reducing recurrent cardiovascular events through evidence-based interventions and biomarker-driven treatment strategies.
- Intensified cardiovascular risk factor management
- Biomarker-driven therapeutic optimization
- Secondary prevention after myocardial infarction
The research focus at Bezirkskrankenhaus St. Johann centers on evaluating novel treatment paradigms that go beyond standard guideline-based care. Through randomized controlled trials, the center investigates residual cardiovascular risk management strategies aimed at improving outcomes in high-risk patient populations who have experienced acute cardiac events, contributing to the advancement of personalized cardiovascular medicine.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1Medical University Of Graz1active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 152 other sites in Austria
Therapeutic Area Benchmark — Austria
Select a therapeutic area to compare against other sites in Austria.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Austria
Market Share
Country: Austria
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Bezirkskrankenhaus St. Johann
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of Biomarker-Driven Intensification of Cardiovascular Risk Management in Patients with High Risk for Recurrent Events Using Icosapent Ethyl and Drug Combination | Medical University Of Graz | Phase III | Recruiting | Jun 2025 | — |
IMP list
lock Showing 1 of 4 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Colchicine | 1 | Unknown | 2025-06-12 | 2025-06-12 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.